Welcome to myAZmed

This is a non-promotional website developed and funded by AstraZeneca and it is intended for UK patients, or their carers, who have been prescribed an AstraZeneca medicine. This website is not intended to replace the discussions between you and your healthcare professional and it is not a substitute for the Patient Information Leaflet which is provided with your medicine.

 

Please select the option below which applies to you.

LEARN ABOUT AN ASTRAZENECA MEDICINE YOU HAVE BEEN PRESCRIBED

If you are a UK patient, or their carer, prescribed an AstraZeneca medicine, please enter myAZmed using the button below.

DISCOVER DISEASE EDUCATION AND SUPPORT FROM ASTRAZENECA

Discover disease education and resources for some of the conditions relevant to AstraZeneca’s work, using the button below.

If you are a UK healthcare professional looking for further information, you can visit our AZ UK Medical Information website.

 

If none of the above options apply, this website is not appropriate for you. To learn more about AstraZeneca as a company you 
can visit astrazeneca.co.uk.

I am a member of the UK public looking for disease education

Intended for UK patients, or their carers, who have been prescribed an AstraZeneca medicine.

logo logo
  • Home
  • AstraZeneca Medicines
  • Disease education

Select the AZ medicine you have been prescribed

Arrange By Text
Latest to Oldest *
  • Latest to Oldest *
  • Oldest to Latest
  • Most relevant to least
  • Least relevant to most
  • Alphabetical (A – Z)
  • Alphabetical (Z - A)

closeFilterLabel Dropdown Filter

Click on the tabs to clear the filtering

Show more

If you can't see your medicine above, click here to access the electronic Medicines Compendium (eMC) where you can access your medicine's Patient Information Leaflet. 

 

×
Description of the image

Lynparza® (olaparib) can be prescribed for more than one condition. To access information relevant to you, please select your condition below.

Breast cancer Prostate cancer Ovarian cancer Endometrial cancer Pancreatic cancer
×
Description of the image

Forxiga® (dapagliflozin) can be prescribed to treat:

  • Type 2 diabetes in children (age 10 – 17 years) OR adults (18+ years)
  • Heart failure in adults (18+ years)
  • Chronic kidney disease (CKD) in adults (18+ years)

For Forxiga information relevant to you, please select the button below which describes you.

I am a child (10 – 17 years), or their carer, with type 2 diabetes I am an adult (18+ years) with type 2 diabetes I am an adult (18+ years) with heart failure I am an adult (18+ years) with CKD
×
Description of the image

Symbicort® Turbohaler® can be prescribed to help manage the symptoms of asthma or COPD. To access information relevant to you, please click your condition below.

I have asthma I have COPD

Reporting side effects

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of medicines.

 

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get as advised above.

logo logo
  • Cookie policy
  • Terms of use
  • Privacy policy
  • Contact us
  • Feedback survey

© Copyright 2026. AstraZeneca Ltd

Approval ID: GB-75660 | Date of preparation: August 2026

Please Rate Your Site Experience

Thank you for the feedback

Please Rate Your Site Experience

Thank you for the feedback

GB-69500 | August 2025